<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39402204</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The short-term and long-term prognosis of discharged COVID-19 patients in Guangdong during the first wave of pandemic.</ArticleTitle><Pagination><StartPage>23994</StartPage><MedlinePgn>23994</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23994</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-76013-9</ELocationID><Abstract><AbstractText>COVID-19 survivors concerning about the rehabilitation and sustained sequelae of Coronavirus Disease 2019 (COVID-19) infection. We aimed to investigate the sequelae of patients' psychological and physical condition and its related factors in the early and late stages. This longitudinal study tracked 281 COVID-19 patients discharged from hospitals in Guangdong, China, for one year. Assessments occurred at 2,4,12,24 and 48 weeks post-discharge. We define 2 weeks, 4 weeks, and 12 weeks as early stage, and 24 weeks and 48 weeks as late stage. Psychological health was measured using the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5), and Pittsburgh Sleep Quality Index (PSQI) scales. Physical health was assessed through laboratory tests, chest computed tomography (CT) scans, and pulmonary function tests. Data were analyzed using multivariate regression models to evaluate the influence of demographic and clinical variables on health outcomes. COVID-19 survivors exhibited psychological and physical sequelae in both the early and late stages. Compared to the early stage, the proportions of patients with depression (early stage 14.6%, late stage 4.6%), anxiety (early stage 8.9%, late stage 5.3%), PTSD(early stage 3.6%, late stage 0.7%), abnormal liver function (early stage 24.6%, late stage 11.0%), abnormal cardiac function (early stage 10.0%, late stage 7.8%), abnormal renal function (early stage 20.6%, late stage 11.0%) and abnormal pulmonary function (early stage 40.9%, late stage 13.5%) were significantly reduced in the late stage. Factors such as gender, age, severity of COVID-19, hospitalization duration, and various comorbidities were significantly associated with these sequelae. We noticed that psychological and physical sequelae occurred to COVID-19 survivors in short and long stages, and these would gradually decrease as time went on. Male gender, age &gt; 50 years old, severe clinical condition, longer hospitalization time and comorbidity history were related factors that significantly affected the rehabilitation of COVID-19 patients.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Pei-Hong</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Graduate College, Shantou University Medical College, Shantou, 515041, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Cheng-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Sun Yat-Sen University 2nd Affiliated Hospital, Guangzhou, 510000, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Zhong-Liang</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shenzhen University General Hospital, Shenzhen, 518055, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yi-Yu</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Guangdong Academy of Medical Sciences, Guangzhou, 510080, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Emergency, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Xiaolan Affiliated Hospital, Southern Medical University, Zhongshan, 528415, Guangdong, China. drfangming@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>, 65 Ju Cheng Avenue Middle Section, 528415, Xiaolan Town, Zhongshan, P.R. China. drfangming@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>No. 2020B1111330006</GrantID><Agency>The Health Commission of Guangdong Province, the Department of Science and Technology of Guangdong Province, and the Special Project on Emergency Response to Control of Novel Coronavirus Infection of Guangdong Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="Y">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013313" MajorTopicYN="N">Stress Disorders, Post-Traumatic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">Physical condition</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Psychological condition</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402204</ArticleId><ArticleId IdType="pmc">PMC11473718</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-76013-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-76013-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>(WHO), W.H.O. Coronavirus disease (COVID-19): Overview. [cited 2024 17/8/2024]; (2023). https://www.who.int/health-topics/coronavirus</Citation></Reference><Reference><Citation>Su, X. et al. Brief report: a cross-sectional study of anxiety levels and concerns of Chinese families of children with special Educational needs and disabilities post-first-wave of COVID-19. Front. Psychiatry. 12, 708465 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8488298</ArticleId><ArticleId IdType="pubmed">34616315</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao, K. et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 22 (12), 757–773 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamana, T. K. et al. The impact of COVID-19 vaccination in the US: averted burden of SARS-COV-2-related cases, hospitalizations and deaths. PLoS One. 18 (4), e0275699 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10129007</ArticleId><ArticleId IdType="pubmed">37098043</ArticleId></ArticleIdList></Reference><Reference><Citation>Berra, T. Z. et al. The COVID-19 pandemic in Brazil: space-time approach of cases, deaths, and vaccination coverage (February 2020 - April 2024). BMC Infect. Dis. 24 (1), 704 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11256571</ArticleId><ArticleId IdType="pubmed">39026177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, Z., Yang, M. &amp; Lai, C. L. Long COVID-19 syndrome: a Comprehensive Review of its effect on various Organ systems and recommendation on Rehabilitation Plans. Biomedicines, 9(8), 996 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriverdi, A. et al. Extrapulmonary features of post-COVID-19 patients: muscle function, physical activity, mood, and sleep quality. Ir. J. Med. Sci. 191 (3), 969–975 (2021). 1971 -).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172250</ArticleId><ArticleId IdType="pubmed">34080125</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Xie, Y. &amp; Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 594 (7862), 259–264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Meherali, S. et al. Mental Health of children and adolescents amidst COVID-19 and Past Pandemics: a Rapid systematic review. Int. J. Environ. Res. Public. Health, 18(7), 3432 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8038056</ArticleId><ArticleId IdType="pubmed">33810225</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong, J. et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J. Affect. Disord. 277, 55–64 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413844</ArticleId><ArticleId IdType="pubmed">32799105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard, N. &amp; Benros, M. E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav. Immun. 89, 531–542 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlapani, E. et al. A review on the COVID-19-related psychological impact on older adults: vulnerable or not? Aging Clin. Exp. Res. 33 (6), 1729–1743 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127443</ArticleId><ArticleId IdType="pubmed">33999378</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferbaum, B. &amp; North, C. S. Mental Health and the Covid-19 pandemic. N. Engl. J. Med. 383(6), 510–512 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32283003</ArticleId></ArticleIdList></Reference><Reference><Citation>Torales, J. et al. The outbreak of COVID-19 coronavirus and its impact on global mental h ealth. Int. J. Soc. Psychiatry 66(4), 317–320 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32233719</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 398 (10302), 747–758 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 10 (9), 863–876 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty, S. E. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 373, n1098 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 588 (7837), 315–320 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H. et al. Demographic, virological characteristics and prognosis of asymptomatic COVID-19 patients in South China. Front. Med. (Lausanne). 9, 830942 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831799</ArticleId><ArticleId IdType="pubmed">35155505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Z. &amp; McGoogan, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323(13): pp. 1239–1242. (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, E. P. H., Hui, B. P. H. &amp; Wan, E. Y. F. Depression and anxiety in Hong Kong during COVID-19. Int. J. Environ. Res. Public. Health, 17(10), 3740(2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7277420</ArticleId><ArticleId IdType="pubmed">32466251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocalevent, R. D., Hinz, A. &amp; Brahler, E. Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen. Hosp. Psychiatry. 35 (5), 551–555 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23664569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W. et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen. Hosp. Psychiatry. 36 (5), 539–544 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25023953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertz, S., Bigda-Peyton, J. &amp; Bjorgvinsson, T. Validity of the generalized anxiety Disorder-7 scale in an acute psychiatric sample. Clin. Psychol. Psychother. 20 (5), 456–464 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22593009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke, K. et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 146 (5), 317–325 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17339617</ArticleId></ArticleIdList></Reference><Reference><Citation>Blevins, C. A. et al. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J. Trauma. Stress. 28 (6), 489–498 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26606250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, D., Kahathuduwa, C. &amp; Vazsonyi, A. T. The Pittsburgh Sleep Quality Index (PSQI): psychometric and clinical risk score applications among college students. Psychol. Assess. 33 (9), 816–826 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34014747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollayeva, T. et al. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep. Med. Rev. 25, 52–73 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26163057</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, D. Q. et al. Application of the Chinese Version of the Pittsburgh Sleep Quality Index in people living with HIV: preliminary reliability and validity. Front. Psychiatry. 12, 676022 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291081</ArticleId><ArticleId IdType="pubmed">34295273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C. et al. Reliability, validity, and Measurement Invariance of the General anxiety disorder scale among Chinese Medical University students. Front. Psychiatry. 12, 648755 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170102</ArticleId><ArticleId IdType="pubmed">34093269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong, X. et al. Validation of the generalized anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 120, 31–36 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26709880</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, G. et al. Analysis of risk factors and construction of a prediction model for posttraumatic stress disorder among Chinese college students during the COVID-19 pandemic. J. Affect. Disord. 362, 230–236 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38969024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, P. et al. Psychometric property study of the posttraumatic stress disorder checklist for DSM-5 (PCL-5) in Chinese healthcare workers during the outbreak of corona virus disease 2019. J. Affect. Disord. 277, 368–374 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443209</ArticleId><ArticleId IdType="pubmed">32861837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, Y. et al. Validation of the 7-item generalized anxiety disorder scale (GAD-7) as a screening tool for anxiety among pregnant Chinese women. J. Affect. Disord. 282, 98–103 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33401129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke, K., Spitzer, R. L. &amp; Williams, J. B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16 (9), 606–613 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer, R. L. et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 166 (10), 1092–1097 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse, D. J. et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28 (2), 193–213 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovin, M. J. et al. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental disorders-Fifth Edition (PCL-5) in veterans. Psychol. Assess. 28 (11), 1379–1391 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26653052</ArticleId></ArticleIdList></Reference><Reference><Citation>Creamer, M., Bell, R. &amp; Failla, S. Psychometric properties of the impact of event scale - revised. Behav. Res. Ther. 41 (12), 1489–1496 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14705607</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger-Gottschalk, A. et al. The German version of the posttraumatic stress disorder checklist for DSM-5 (PCL-5): psychometric properties and diagnostic utility. BMC Psychiatry. 17 (1), 379 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5704375</ArticleId><ArticleId IdType="pubmed">29183285</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus, J. et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J. Psychosom. Res. 53 (3), 737–740 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12217446</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri, M. et al. Measuring subjective sleep quality: a review. Int. J. Environ. Res. Public Health. 18(3), 1082 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908437</ArticleId><ArticleId IdType="pubmed">33530453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocalevent, R. D., Hinz, A. &amp; Brähler, E. Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen. Hosp. Psychiatry. 35 (5), 551–555 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23664569</ArticleId></ArticleIdList></Reference><Reference><Citation>Löwe, B. et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med. Care. 46 (3), 266–274 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18388841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. et al. Transmission dynamics of an outbreak of the COVID-19 Delta variant B.1.617.2 - Guangdong Province, China, May-June 2021. China CDC Wkly. 3 (27), 584–586 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392962</ArticleId><ArticleId IdType="pubmed">34594941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, M. et al. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. Euro. Surveill. 27(10), 2100815 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8915401</ArticleId><ArticleId IdType="pubmed">35272744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed, K. et al. COVID-19 vaccinations: the unknowns, challenges, and hopes. J. Med. Virol. 94 (4), 1336–1349 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015467</ArticleId><ArticleId IdType="pubmed">34845731</ArticleId></ArticleIdList></Reference><Reference><Citation>Araf, Y. et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 94 (5), 1825–1832 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015557</ArticleId><ArticleId IdType="pubmed">35023191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. et al. A look back at the first wave of COVID-19 in China: a systematic review and meta-analysis of mortality and health care resource use among severe or critical patients. PLoS One. 17 (3), e0265117 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8916647</ArticleId><ArticleId IdType="pubmed">35275943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F. et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 101, 93–135 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues, E. et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 81 (6), e4–e6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397 (10270), 220–232 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez, R. et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J. Intern. Med. 290 (3), 621–631 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit, D. et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Med. 20 (1), 50 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, X. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 9 (7), 747–754 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte, Á. et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 19 (1), 129 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Q. et al. Long-term sequelae of COVID-19: a systematic review and Meta-analysis of one-year Follow-Up studies on Post-COVID symptoms. Pathogens. 11(2), 269 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler, R. C. et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry. 52 (12), 1048–1060 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7492257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandifar, A. et al. Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. J. Diabetes Metab. Disord. 19 (2), 1431–1438 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594988</ArticleId><ArticleId IdType="pubmed">33145259</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y. et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 6 (3), 211–224 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30792114</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti, F. et al. Neuroinflammation in Bipolar Depression. Front. Psychiatry. 11, 71 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054443</ArticleId><ArticleId IdType="pubmed">32174850</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, B. J. et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry. 70 (7), 663–671 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071300</ArticleId><ArticleId IdType="pubmed">21641581</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton, C. D., Pickup, J. C. &amp; Ismail, K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 3 (6), 461–471 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25995124</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar, S. et al. Neuroinflammation and psychiatric illness. J. Neuroinflammation. 10, 43 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3626880</ArticleId><ArticleId IdType="pubmed">23547920</ArticleId></ArticleIdList></Reference><Reference><Citation>Renna, M. E. et al. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: a systematic review and meta-analysis. Depress. Anxiety. 35 (11), 1081–1094 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30199144</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveiros, A. et al. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Am. J. Physiol. Heart Circ. Physiol. 320 (1), H296–H304 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083171</ArticleId><ArticleId IdType="pubmed">33275517</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso, G. et al. Emerging liver-kidney interactions in nonalcoholic fatty liver disease. Trends Mol. Med. 21 (10), 645–662 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26432021</ArticleId></ArticleIdList></Reference><Reference><Citation>Renu, K., Prasanna, P. L., Valsala, A. &amp; Gopalakrishnan Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci. 255, 117839 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243768</ArticleId><ArticleId IdType="pubmed">32450165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu, L. A. et al. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc. Res. 116 (14), 2197–2206 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin, D. D. &amp; Man, S. F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 107 (11), 1514–1519 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12654609</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hadi, H. et al. Relationship between Heart Disease and Liver Disease: a two-Way Street. Cells. 9(3), 567 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7140474</ArticleId><ArticleId IdType="pubmed">32121065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, L. et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 10 (11), e042573 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656886</ArticleId><ArticleId IdType="pubmed">33172950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir, S. Hantavirus Induced kidney disease. Front. Med. (Lausanne). 8, 795340 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8804099</ArticleId><ArticleId IdType="pubmed">35118091</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl, H. &amp; Lang, S. M. Long-term interplay between COVID-19 and chronic kidney disease. Int. Urol. Nephrol. 55(8),1977–1984 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9955527</ArticleId><ArticleId IdType="pubmed">36828919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, S. L. et al. Patterns of deterioration in moderate patients with COVID-19 from Jan 2020 to Mar 2020: a Multi-center, Retrospective Cohort Study in China. Front. Med. (Lausanne). 7, 567296 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744800</ArticleId><ArticleId IdType="pubmed">33344469</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395 (10223), 497–506 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls, B. G. et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 11 (1), e044640 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. J. et al. Risk and protective factors for COVID-19 morbidity, severity, and Mortality. Clin. Rev. Allergy Immunol. 64 (1), 90–107 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>